Auxilium Pharmaceuticals Inc
(NASDAQ: AUXL)
-0.08
-0.52%
Auxilium Pharmaceuticals Inc, a small-cap growth company in the health care sector, is expected to outperform the market over the next six months with average risk.
10 is the best possible rating.
Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
The price-to-earnings multiple is lower than average for all stocks in the StockScouter universe. Positive
ConThe most recent quarterly earnings report was significantly lower than analysts' consensus forecast. Negative
The StockScouter measure of relative price change and consistency is low. Negative
The most recent quarterly earnings report was significantly lower than analysts' consensus forecast. Negative
Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
One or more analysts has significantly increased quarterly earnings estimates for AUXL. Positive
Executives, board directors or major shareholders have bought and sold shares recently. Neutral
Shares are being heavily sold by financial institutions. Neutral for a small company like AUXL
The price-to-earnings multiple is lower than average for all stocks in the StockScouter universe. Positive
The price-to-sales multiple is slightly higher than the average for all stocks in the StockScouter universe. Negative for a small company like AUXL
The ratio of AUXL's price-to-earnings multiple to its five-year growth rate is about the same or slightly above the average of all stocks in the StockScouter universe. Positive
The StockScouter measure of relative price change and consistency is low. Negative
Previous day's closing price for AUXL was slightly below its 50-day moving average. Negative
data provided by Verus Analytics
Learn more about the StockScouter rating system.
Page generated 5/25/2013 1:59 AM ET
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
